The knowledge and relevance of nutrition as well as the demand for well-funded advices increase. The Cochrane Collaboration plays a leading role within the evidence-based medicine and practice. We advocate therefore more specialized nutritional interest within the Cochrane Collaboration. In case 'Nutrition' needs more attention within the Cochrane Library, one of the first priorities is deciding about whether to include non-randomized studies into the Specialized Register and generating lists of journals to handsearch for such a Specialized Register. Preparatory to these activities an inventory of Nutritional content within the Cochrane Library is needed. We estimate that reviews directly related to nutrition and those of borderline interest to nutrition represent less than 4% of all published reviews in The Cochrane Library.
Introduction
The Cochrane Collaboration is the golden Evidence Based Standard. So far most of us will be in line (Scholten et al, 2005) .
Difficulties arise as soon as transversal topics in medicine, like nutrition, will be considered with the Cochrane way of view. Nutrition is transversal, involved in a large number of diagnoses and is not an isolated topic but interwoven in the treatment and prevention of the disease in question (van Binsbergen, 1997) .
The heterogeneity of the survey population and the different amounts and compositions of food eaten makes standardized and extensive trials expensive and almost unfeasible. For primary care, it is in addition essential that this must be achieved for patients and families of all socialcultural backgrounds before it can be pursued in routine care not just for a happy few with special nutritional interests or a specific health status. Research should also include the role of the individual provider, for example of dieticians and family doctors, with regard to nutritional advice. (van Binsbergen & Drenthen, 2003) An additional problem with the effectiveness of nutrition is the time-window between application and health effects of many years, a time-window that can virtually never be covered in randomized controlled trials that are usually limited to a couple of years. Randomized controlled clinical trials alone will, therefore, be insufficient to prove the significance of an individual nutritional intervention on the basis of clinical end points. Pathophysiological background knowledge leading to the development of intermediary end points as well as critical interpretation of observational studies must also be employed. These approaches face methodological objections (Reeves et al, 2005) .
In case 'Nutrition' needs more attention within the Cochrane Library, one of the first priorities is deciding about whether to include non-randomized studies into the Specialized Register and generating lists of journals to hand search for such a Specialized Register. Preparatory to these activities an inventory of Nutritional content within the Cochrane Library is needed.
A systematic review is a review that strives comprehensively to identify and synthesize all the literature meeting the a priori inclusion criteria, which stem from the question being asked. The unit of analysis is the primary study, and the same scientific principles and rigour apply to systematic reviewing as to primary research. If a review does not state clearly whether and how all relevant studies were identified and synthesized, it is not a systematic review. Cochrane reviews undergo a strict quality control check at the protocol and review stages, which ensures that all Cochrane reviews are systematic. Systematic reviews are a better source of evidence compared with other reviews by reducing conscious and unconscious bias. Where data are in a form suitable for meta-analysis, this provides a more precise, and less biased, estimate of the effect size.
Output of the Cochrane Library
The science of nutrition contains many unanswered questions. By conducting systematic reviews, and meta-analyses if appropriate, we may be able to answer some of these questions now rather than wait for the results of the definitive study to be conducted or published. Indeed, Garrow wrote an editorial in the European Journal of Clinical Nutrition in 1992 on the value of meta-analyses in clinical nutrition (Garrow, 1992) . At that time, very few Cochrane reviews relating to nutrition had been conducted. By 2004, the number had increased substantially. Although this substantial increase in activity is good news, we estimate that reviews directly related to nutrition and those of borderline interest to nutrition represent less than 4% of all published reviews in The Cochrane Library.
Therefore, we excluded substances such as, herbs, caffeine for asthma, garlic for colds, etc. as being herbal medicine. (Number of herbal intervention reviews ¼ 31). We also excluded titles where nutrition was not explicitly mentioned, even though it might be part of the review (eg 'Selfmanagement strategies for adults with Type 1 diabetes').
We included substances regarded as nutrients even when used in larger, therapeutic doses, that is, not dietary but probably still counting as nutritional. Subsequently, an exploratory survey gave the following results.
Total Cochrane reviews on the Library (Cochrane, 2004) : 4697 registered titles, including 2074 completed reviews (R). The other 2623 are still in production-either protocol stage (P) or registered title only (T). Table 1 gives an overview of the Cochrane nutritionrelated topics. We have looked at all the registered titles, working our way through the Library by review groups, of which there are 49, as stated. Being fairly generous in what we have considered to be a nutrition intervention, we have come up with the following: 183 (3.9%) of all registered titles are on nutrition interventions, while just 57 (2.7%) of completed reviews are on nutrition interventions.
Discussion
It is remarkable that the percentage is much lower on completed reviews than on registered; some of the incomplete nutrition reviews are fairly new but a lot have been in production for 3 y or more, suggesting reviewers who take on a nutrition intervention find it harder to complete the task.
Moreover, there are so many registered titles (48 (26%)) within the Neonatal group, mainly on formula feeds, but very few are completed. The other 'big' groups are Metabolism, as you would expect (23 (13%)) and pregnancy/ childbirth (30 (16%)) who are the longest established, largest and most active group.
What strikes is the fact that very little is generated by the Heart, Stroke and Hypertension groups, and that a topic like undernutrition/malnutrition or nutritional deficiency is underexposed.
Most reviews look at interventions used in a clinical (not public health/community) setting. However, in some cases, the findings would be of potential significance for public health/community interventions.
There are number of possible reasons why so few Cochrane reviews are related to nutrition . The first is that, while there is a precedent for evidence-based medical care, this has yet to impact fully on nutritional care. Although there is a view by some academics that the systematic review process is not relevant to nutrition, we would argue that nutrition is not different from other health care interventions and that a systematic review of the evidence base for nutrition interventions is essential. Nutritionists are lagging behind other health-related disciplines in terms of collating the evidence base, which is ironic given that the first published systematic review was Lind's Treatise on Scurvy (Lind).
Another reason for why so few Cochrane reviews are related to nutrition is that reviewers are less willing to undertake reviews where they feel there is little good evidence. It is true that there is a relative dearth of trials of nutrition interventions (except in the neonatal and infant nutrition areas), probably because funding for such trials is on a much smaller scale compared to the funding of drug trials. Indeed, many published trials of nutrition interventions are not funded (they may have been part of a project for a higher degree), and involve small numbers of patients. Systematic reviews and meta-analysis are particularly useful when the evidence base consists of trials containing small sample sizes, or where the effect size is small, or where the outcome is rare (ie when the numbers of individuals needed to be studied is large). Systematic reviews on the effectiveness of nutrition interventions or initiatives where randomized controlled trials have not been conducted or are not appropriate (eg community or public health nutrition interventions) have not traditionally been carried out within the Cochrane Collaboration. However, over the last few years, driven by the Health Promotion and Public Health (HPPH) Field, such reviews are beginning (slowly) to appear in the Cochrane Library. In addition, the HPPH Field are encouraging reviewers to update their reviews, where appropriate, using HPPH Field protocol-the review 'Interventions for preventing obesity in children' is currently being updated on this basis. However, the vast majority of systematic reviews on community or public health nutrition are not Cochrane reviews at present. These reviews are published elsewhere, and they can be difficult to search for since they are often published in the grey literature, for example: As stated elsewhere in this Journal, there is a need for a more transversal look at the longitudinal nutritional topics within medicine in general and the Cochrane Library in particular . We believe that a Cochrane Diet and Nutrition (Sub) Field would be able to facilitate the coordination and promotion of nutrition-related Cochrane reviews. This would initiate the identification and collation of good quality systematic reviews completed outside the Cochrane Collaboration, and work with the reviewers to convert such reviews into Cochrane reviews. Moreover, such a (Sub) Field would be able to reduce the level of duplication thus allowing reviewers to work in areas of nutrition where the need is greatest and being responsible for the promotion of evidence-based nutrition interventions throughout the world (Lodge et al, 2005) . The evidence base for nutrition interventions should be accessible to researchers, healthcare providers and policy makers, not just in the developed world but also in resource-poor settings where the most severe nutrition problems exist.
Conclusion
The knowledge and relevance of clinical nutrition within medicine is increasing. Methodological pitfalls restrain randomized controlled trials on this topic. The cry for evidence-based practice is everywhere and the Cochrane Collaboration plays a key role here. The core task for the near future is to be sure: 'that nutritionists are not left behind in the move towards the evidence-based approach'. However, there is just one condition for success: protocol writers and subsequently doctors should use these evidence-based outcomes actively. Table 1 Nutrition related topics within the Cochrane Library, assigned to the main review groups including completed reviews (R) or still in production-either protocol stage (P) or registered title only (T) Acute respiratory infections Group 5 (3 complete) Probiotics for preventing acute otitis media in children T Vitamin A for nonmeasles pneumonia in children P Vitamin A for treating measles in children R Vitamin C for preventing and treating the common cold R Zinc for the common cold R Anaesthesia Group 4 (0 complete) Nutritional support for adult intensive care patients P Nutritional support for nutritional depletion in survivors of critical illness T Nutritional support for patients admitted to a paediatric intensive care unit T Selenium supplementation for critically ill patients P Airways 4 (2 complete) Dietary avoidance of cow's milk proteins for preventing asthma in children P Dietary marine fatty acids (fish oil) for asthma R Dietary salt reduction or exclusion for allergic asthma P Vitamin C supplementation for asthma R Back 0 Breast cancer 0 Colorectal cancer 6 (2 complete) Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps R Dietary fibre for the prevention of colorectal adenomas and carcinomas R Early enteral nutrition within 24 h of colorectal surgery vs later commencement of feeding for postoperative complications P Iron nutrition for colorectal cancer P Preoperative enteral nutrition for colorectal surgery T Vitamins and minerals for the prevention of colorectal adenomas and carcinomas P
Consumers and Communications 0
Cystic fibrosis and genetic disorders 3 (3) Dietary advice for illness-related malnutrition in adults R Dietary interventions for phenylketonuria R Dietary treatment for familial hypercholesterolaemia R Dementia and cognitive improvement 4 (4) Folic acid for dementia R Vitamin B12 for dementia R Vitamin B6 for cognition R Vitamin E for Alzheimer's disease R Depression, anxiety and neurosis 3 (0) Polyunsaturated fatty acids for the prevention or treatment of bipolar disorder in adults T Polyunsaturated fatty acids for mood disorders T Self-help and guided self-help for eating disorders T Developmental, psychosocial and learning problems 2 (2) Dietary interventions for recurrent abdominal pain in childhood R Growth monitoring in children R Drugs and alcohol 0 Ear, nose and throat 0 Effective practice and organization of care 1 (1) Dietary advice given by a dietitian vs other health professional or self-help methods to reduce blood cholesterol R
Epilepsy 0
Eyes and vision 2 (1) Antioxidant supplementation for preventing age-related cataract P Antioxidant vitamin and mineral supplementation for preventing age-related macular degeneration R
Fertility regulation 0
Gynaecological cancer 4 (0) Nutritional interventions for acute and late radiation-induced bowel damage in patients who have received pelvic radiotherapy T Nutritional support in children with cancer undergoing chemotherapy P Selenium for preventing cancer T Zinc supplements for disorders of taste in cancer patients T
Haematological malignancies 0
Heart 3 (0) Fruit and vegetables for cardiovascular disease P Supplemental plant sterols and stanols for serum cholesterol and cardiovascular disease T Wholegrain cereals and dietary fibre for coronary heart disease T Hepato-biliary 1 (0) Vitamin K for upper gastrointestinal bleeding in patients with liver diseases T HIV/AIDS 3 (1) Balanced diet for reducing morbidity and mortality in HIV-infected individuals P Micronutrient supplementation to reduce morbidity and mortality in HIV-infected children and adults P Vitamin A supplementation during pregnancy for decreasing mother-to-child transmission of HIV infection R Hypertension 4 (2) Calcium supplements for the management of essential hypertension in adults P Combined calcium, magnesium and potassium supplementation for the management of essential hypertension in adults P Dieting to reduce body weight for controlling hypertension in adults R Effects of low sodium diet vs high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols and triglyceride R Incontinence 0
Infectious diseases 2 (0) Early vs late feeding for gastroenteritis in children T (Oral rehydration vs intravenous rehydration therapy for treating dehydration due to gastroenteritis in children P-not counted) Oral zinc for treating diarrhoea in children T (Rice-based oral rehydration solution for treating diarrhoea R-not counted)
Inflammatory bowel disease 3 (0)
Probiotics for Clostridium difficile-associated colitis in adults T Menstrual disorders and subfertility 2 (0) Vitamin B6 for premenstrual syndrome P Zinc for male subfertility T Metabolic and endocrine disorders 23 (9) Acupuncture for obesity T Advice on low-fat diets for obesity R Chitosan for overweight and obesity P Chromium supplements for obesity T Commercial weight loss programmes for obesity T Dietary advice for treatment of type II diabetes mellitus in adults R Exercise for obesity P Fish oil in people with type II diabetes mellitus R Glycaemic index diets for physical activity in athletes T Intragastric balloon for obesity P Iodine supplementation for preventing iodine deficiency disorders R Iodised salt for preventing iodine deficiency disorders R Long-term weight loss interventions for type II diabetes mellitus in adults P Low glycaemic index diet for people with diabetes mellitus T Low glycaemic index or low glycaemic load diets for overweight and obesity T Magnesium for hypomagnesemia T Oral vitamin B12 for vitamin B12 deficiency P Protein and energy supplementation in the elderly people at risk from malnutrition R Protein restriction for diabetic renal disease R Psychological interventions for obesity P Surgery for morbid obesity R Weight loss interventions for adults with pre-diabetes T Weight reduction for reducing mortality in obesity and overweight P Methodology 0 Movement disorders 0 Multiple sclerosis 0 Muskuloskeletal 5 (2) Calcium and vitamin D for corticosteroid-induced osteoporosis R Calcium for osteoporosis in postmenopausal women P Calcium supplementation for improving bone mineral density in children T Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis R Vitamin D with or without calcium for osteoporosis in postmenopausal women P Muskuloskeletal injuries 2 (2) Nutritional supplementation for hip fracture aftercare in the elderly R Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis R Neonatal 48 (6) 1500 vs 3000 IU vit A/day for formula-fed preterm infants T 2000 IU vit A/day vs saline for preterm infants receiving IPPV at 72 h T Calcium and phosphate supplementation of human milk for promoting growth in preterm infants P Caloric supplementation of human milk for promoting growth in preterm infants P Calorie and protein-enriched formula (preterm formula) vs human breast milk for improving growth and development in preterm or low birth weight infants following hospital discharge T Calorie and protein-riched formula (preterm formula) vs standard calorie (term formula) for improving growth and development in preterm or low birth weight infants following hospital discharge T Carbohydrate supplementation of human milk to promote growth in preterm infants R Carnitine supplementation of parenterally fed neonates P Cisapride for feeding problems in the preterm infant T Continuous nasogastric milk feeding vs intermittent bolus milk feeding for premature infants less than 1500 g P Table 1 Continued Different amino-acid formulations for parenterally fed neonates T Early amino acids for parenterally fed neonates T Early amino acids for paretnerally fed neonates T Early vs delayed initiation of progressive enteral feedings for parenterally fed low birth weight or preterm infants R Elemental formula feeding of infants for prevention of atopy and food intolerance T Folate supplementation for low birth weight infants T Folate supplementation for low birth weight infants T High vs low medium chain triglyceride content in formula in low birth weight infants NS T Higher vs lower target intakes of calcium and phosphorus for parenterally fed neonates T Human milk feeding of infants for prevention of atopy and food intolerance T Hydrolysed formula feeding of infants for prevention of atopy and food intolerance T Iodine supplementation for low birth weight infants T Iron supplementation for enterally fed preterm infants T Iron supplementation for human milk fed preterm or low birth weight infants following hospital discharge T Iron supplementation for preterm newborns T Iron supplementation for vitamin E-deficient preterm newborns T Iron supplementation for vitmain E-sufficient preterm newborns T Iron supplementation in erythropoietin-treated newborn infants NS T Lactase-treated feeds for the preterm infant and its effects on growth and feeding tolerance T Long-chain polyunsaturated fatty acid supplementation in infants born at term R Long-chain polyunsaturated fatty acid supplementation in preterm infants R Maternal food elimination diet for breasting mother-infant pairs with family history of atopy T Maternal food elimination diet in breastfeeding mothers of infants with colic NS T Preterm formula milk vs term formula milk for feeding preterm or low birth weight infants T Protein-enriched formula vs banked term human milk in preterm or low birth weight infants NS T Protein-enriched formula vs preterm human milk in low birth weight infants NS T Protein supplementation of human milk for promoting growth in preterm infants R Protein-enriched formula vs banked term human milk for preterm or low birth weight infants T Selenium supplementation for term infants T Soy milk feeding of infants for prevention of atopy and food intolerance T Supplemental oral vitamin D for preterm infants T Supplementation of minerals or trace elements for human milk fed preterm or low birth weight infants following hospital discharge T Vitamin A supplementation for preventing morbidity and mortality in very low birth weight infants R Vitamin E supplementation for preterm newborns T Vitamin K for preventing haemorrhagic disease in newborn infants P Vitamin supplementation for human milk fed preterm or low birth weight infants following hospital discharge T Zinc supplementation for prevention of morbidity and mortality in enterally fed term and preterm infants T Zinc supplementation for prevention of morbidity and mortality in parenterally fed term and preterm infants T Neuromuscular disease 1 (0) Vitamin B for treating peripheral neuropathy P Oral health 1 (0) Fluoridated milk for preventing dental caries in children and adolescents P Pain, palliative and supportive care 2 (1) Nutrition support for bone marrow transplant patients R Nutritional screening for improving patient outcomes in hospital and primary care settings T Peripheral vascular diseases 2 (2) Vitamin E for intermittent claudication R Vitamin K antagonists or low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism R Pregnancy and childbirth 30 (13) Additional foods and fluids for breastfed full-term infants P Antenatal nipple care for increasing the duration of breastfeeding P Balanced protein/energy supplementation in pregnancy R Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems R Calcium supplementation for treating hypertensive disorders of pregnancy T Drugs to increase milk supply in the breastfeeding mother T Early compared with delayed oral fluids and food after caesarean section R Early vs delayed initiation of breastfeeding R Fish oil and other prostaglandin precursor supplementation during pregnancy for reducing pre-eclampsia, preterm birth, low birth weight and intrauterine growth restriction P Folate supplementation in pregnancy R Health information about food-borne infections for pregnant women T Interventions for promoting the initiation of breastfeeding P Iron and folate supplementation in pregnancy R Iron supplementation in pregnancy R Maternal iodine supplements in areas of deficiency R Maternal nutrient supplementation for suspected impaired fetal growth R Nutritional interventions before and during pregnancy for phenylketonuria in women P Pyridoxine (vitamin B6) supplementation in pregnancy R Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy R Restricting oral fluid and food intake during labour P Treatments for iron deficiency anaemia during pregnancy R Vitamin A supplementation during pregnancy R Vitamin A supplementation for breastfeeding mothers T Vitamin C supplementation in pregnancy P Vitamin D supplementation in pregnancy R Vitamin E supplementation in pregnancy P Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage R Vitamin supplementation for preventing miscarriage P Vitamins for the prevention and treatment of pre-eclampsia and associated conditions in pregnancy T Zinc supplementation in pregnancy R 
